- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
'Full-service rep' loves her job
Jill Shoffner-Brown loves satisfying the customer and hearing success stories about her products.
When asked what aspects of her career keep her motivated, Jill Shoffner-Brown, a pharmaceutical sales rep for Boehringer Ingelheim Corp., replies, "I really just love my job. I love satisfying the customer and hearing success stories about my product(s)."
Shoffner-Brown considers herself a "full-service rep," meaning she takes care of everything for her physicians. "I talk to the office manager and make sure I have supplied him or her with all the information he or she may need," she said. "I leave patient-education materials if needed. I also make sure I know where the samples are so I can take inventory without having to disturb the physician."
Being a full-service rep also means understanding managed care and formularies. "Managed care is a huge part of the business," Shoffner-Brown said. "Reps need to know a physician's plans and what products are on the formularies. A rep should also find out if his or her competition's products are on the formulary, and if so, report these to his or her district manager."
Another part of being a full-service rep is understanding a physician's work.
Shoffner-Brown finds preceptorships useful for reps. "A preceptorship allows reps to increase their knowledge about diseases and human anatomy," she said. "It's like watching a case history; you can see a physician prescribe your drug and see how physicians use the information you supply them. It also builds rapport with that physician and any other attending physicians. Preceptorships make a rep really feel like a team player."
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to Start
October 30th 2024By demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.
